Drugs Made In America Acquisition DMAA
NASDAQ DMAA
$10.91 +0.01 (+0.09%)
At close: Nov 13, 2026 · 4:00 PM EST

Drugs Made In America Acquisition (DMAA) EBIT (2024 - 2026)

Updated

Drugs Made In America Acquisition's EBIT was -$136,934 in Q2 2026, compared with -$131,919 a year earlier.

Analysis

Drugs Made In America Acquisition (DMAA) EBIT (2024 - 2026) Analysis & Trends

On a trailing twelve-month basis, Drugs Made In America Acquisition's EBIT was -$2.62 million through Jun 30, 2026; for FY2025, it came in at -$2.82 million.

  • In earlier years, EBIT was -$279,845 in FY2024.
  • Quarterly EBIT has moved between -$2.09 million (Q4 2025) and -$131,919 (Q2 2025) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 BlackRock 189.07 Bn 145.60 Bn - 2.33 Bn
2 Spdr Gold Trust 125.11 Bn -432.90 Bn - -
3 Brookfield 101.47 Bn -96.66 Bn - -
4 Blackstone 91.35 Bn 85.56 Bn - 1.66 Bn
5 Kkr 87.89 Bn 54.59 Bn 1.76 Bn -1.96 Bn
6 Brookfield Asset Management 82.34 Bn 77.22 Bn - 3.39 Bn
7 Apollo Global Management 72.94 Bn 89.74 Bn 4.14 Bn -1.39 Bn
8 Wheaton Precious Metals 59.70 Bn 59.70 Bn 538.50 Mn 511.01 Mn
9 Ares Management 48.49 Bn 47.07 Bn 376.28 Mn -772.25 Mn
10 Drugs Made In America Acquisition 336.16 Mn 336.12 Mn - -136,934.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -136,934.00
Mar 31, 2026 -143,301.00
Dec 31, 2025 -2.09 Mn
Sep 30, 2025 -263,703.00
Jun 30, 2025 -131,919.00
Mar 31, 2025 -330,925.00
Dec 31, 2024 -79,986.00
Sep 30, 2024 -144,928.00
API Access

Drugs Made In America Acquisition EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=DMAA&period=max&api_key=YOUR_API_KEY